The World Health Organization has warned that the Zika R&D frenzy may not culminate in a vaccine in time for the current outbreak, but Sanofi Chief…

As Sanofi works to gain traction for the launch its world-first dengue vaccine, a potential competitor is building its case.

Just last month, Sanofi became the first Big Pharma player to enter the Zika vaccine R&D space as its peers calculated their responses and weighed…

A vaccine developed in collaboration between GlaxoSmithKline and the U.S. Army failed to protect subjects in an early trial against the world's most…

Vaccine companies and research organizations worldwide continued to race againstZikathis week, with a new entrant emerging in Gaithersburg, MD-based Novavax.…

Several players are working on vaccines for Middle East Respiratory Syndrome (MERS), including the NIH and tandem GeneOne and Inovio, both of which had…

A team of scientists has created the first 3-D "map" of a protein used by malaria parasites to invade human blood cells. This could lead to the…

With flu season in full swing, Mitsubishi Tanabe has its eyes on the horizon as it aims to get its quick-to-produce, tobacco-based flu vaccine on the market by…

Russian Health Minister Veronika Skvortsova announced that an Ebola vaccine developed in that country did well in Phase I and II trials, and will enter further…

Zikadevelopments continued at an accelerated pace this week with the WHO saying that India's Bharat Biotech and the United States' National…